CYP2D6 polymorphisms influence tamoxifen treatment outcomes in

Pharmacogenetics and Psychiatric Care: A Review and Commentary

Full article: CYP2D6 polymorphisms influence the efficacy of adjuvant tamoxifen in Thai breast cancer patients

Genetic polymorphisms on the effectiveness or safety of breast cancer treatment: Clinical relevance and future perspectives - ScienceDirect

Simplistic representation of the main biotransformation of tamoxifen

CYP2D6 Genotype–Guided Tamoxifen Dosing in Hormone Receptor–Positive Metastatic Breast Cancer (TARGET-1): A Randomized, Open-Label, Phase II Study

Association of single nucleotide polymorphisms of cytochrome P450 enzymes with experience of vasomotor, vaginal and musculoskeletal symptoms among breast cancer patients: a systematic review, BMC Cancer

Full article: Impact of CYP2D6*4 genotype on progression free survival in tamoxifen breast cancer treatment

Influence of CYP2D6 Polymorphisms on Serum Levels of Tamoxifen Metabolites in Spanish Women with Breast Cancer

CYP2D6 genotype- and endoxifen-guided tamoxifen dose escalation increases endoxifen serum concentrations without increasing side effects. - Abstract - Europe PMC